There were 778 press releases posted in the last 24 hours and 186,354 in the last 365 days.

Vaccine Market Trending factors & Growth Drivers Impact Globally

Emergen Research Logo

Emergen Research Logo

Rise in prevalence of infectious diseases and increased investment in vaccine development activities are some key factors driving market revenue growth

VANCOUVER, BC, CANADA, January 6, 2022 / -- The global Vaccine Market size is expected to reach USD 77.90 Billion at a steady revenue CAGR of 7.1% in 2028, according to latest analysis by Emergen Research. An increase in prevalence of infectious diseases is a key factor driving global vaccine market revenue growth.

Rise in prevalence of infectious diseases globally increases the healthcare burden of diseases on countries and affects their socio-economic development. Emergence of drug-resistant microbial strains that have affected the fight against infectious diseases such as pneumonia, cholera, malaria, and diarrhea, among others. Rising demand for new drugs to replace those that have lost effectiveness and investment in research and development of vaccines is augmenting growth of the market.

The newest research on the Vaccine market applies both qualitative and quantitative data analysis to present an overview of the future adjacencies around the Vaccine industry for the forecast period, 2020-2028.

Download Sample Copy of this Report@

Some Key Highlights

In August 2021, Pfizer and BioNTech announced a collaboration with Brazil’s Eurofarma to manufacture COVID-19 vaccine doses for Latin American countries. COMIRNATY will be manufactured by Eurofarma with Pfizer’s and BioNTech’s COVID-19 vaccine manufacturing and supply chain network. Eurofarma will get raw materials for the drug from the U.S. and manufacturing will begin in 2022. Vaccine production is expected to exceed 100 million finished doses yearly which will be exclusively distributed within Latin America.

Monovalent vaccine segment revenue is expected to register a significant growth rate during the forecast period. A monovalent vaccine is designed to immunize single microorganism and antigen (for example, measles vaccine). This type of vaccine is preferable for development of a strong immune response.

 The research report offers in-depth insights into company profiles along with their production values, production capacity, product portfolio, strategic plans such as mergers and acquisitions, joint ventures, collaborations, product launches and brand promotions, government and corporate deals, among others. The report, additionally, offers a comprehensive SWOT analysis and Porter’s Five Forces analysis to offer a better understanding of the competitive landscape of the industry.

Leading Players Profiled in the Report:

Pfizer, Inc., CSL Limited, Merck & Co., Inc., AstraZeneca, Johnson & Johnson, Serum Institute of India Pvt., Ltd., GlaxoSmithKline PLC, Sanofi Pasteur SA, Emergent Biosolutions, Inc., and Biological E.

Request for discount@

 Regional Bifurcation of the Vaccine Market Includes:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

The report aims to provide a complete analysis of the global Vaccine market with important details about the key market players from insightful primary and secondary research data. The report also aims to benefit the user by providing constructive data to gain insight into market growth, size, and investment approaches. Additionally, the report provides an extensive analysis of the Vaccine market, including key data, such as factors influencing the growth of the market, buyers and vendors, production and consumption, and revenue.

Proceed To Buy@

Key Benefits of Buying the Global Vaccine Report:

Comprehensive analysis of the changing competitive landscape

Assists in decision making processes for the businesses along with detailed strategic planning methodologies

The report offers an 8-year forecast and assessment of the Global Vaccine Market

Helps in understanding the key product segments and their estimated growth rate

In-depth analysis of market drivers, restraints, trends, and opportunities

Comprehensive regional analysis of the Global Vaccine Market

Extensive profiling of the key stakeholders of the business sphere

Detailed analysis of the factors influencing the growth of the Global Vaccine Market

Emergen Research has segmented the global Vaccine market on the basis of type, patient type, technology, disease, route of administration, and region:

Type Outlook (Revenue, USD Billion; 2018-2028)

Monovalent Vaccines

Multivalent Vaccines

Patient Type Outlook (Revenue, USD Billion; 2018-2028)

Pediatric Patients

Adult Patients

Technology Outlook (Revenue, USD Billion; 2018-2028)

Inactivated & Subunit Vaccines

Conjugate Vaccines

Recombinant Vaccines

Live Attenuated Vaccines

Toxoid Vaccines

 Enquire for customization in Report @:

 Thank you for reading our report. The report can be customized as per requirement. Please get in touch with us for further inquiry and we will ensure you get the report best suited for your needs.

Explore Similar Reports offered by Emergen Research:

Lightweight Materials Market@

Ambulatory EHR Market@

Drone Package Delivery Market@

Structured Cabling Market@

Molecular Imaging Market@

About Us:

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Eric Lee
Emergen Research
+91 90210 91709
Visit us on social media: